Mirae Asset Global Investments
AUPH icon

Mirae Asset Global Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

Mirae Asset Global Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.6K Sell
5,752
-1,184
-17% -$18.9K ﹤0.01% 1240
2026
Q1 		$103K Buy
6,936
+529
+8% +$7.73K ﹤0.01% 1175
2025
Q4 		$102K Buy
6,407
+1,318
+26% +$18.7K ﹤0.01% 1253
2025
Q3 		$56.2K Sell
5,089
-130
-2% -$1.42K ﹤0.01% 1323
2025
Q2 		$44.2K Buy
5,219
+623
+14% +$4.99K ﹤0.01% 1279
2025
Q1 		$38.1K Sell
4,596
-175
-4% -$1.42K ﹤0.01% 1290
2024
Q4 		$43.9K Sell
4,771
-401
-8% -$3.27K ﹤0.01% 1285
2024
Q3 		$37.7K Buy
5,172
+902
+21% +$5.59K ﹤0.01% 1347
2024
Q2 		$24K Sell
4,270
-55,565
-93% -$293K ﹤0.01% 1356
2024
Q1 		$632K Sell
59,835
-4,170
-7% -$28.3K ﹤0.01% 1791
2023
Q4 		$575K Buy
64,005
+217
+0.3% +$1.79K ﹤0.01% 1898
2023
Q3 		$496K Buy
63,788
+5,012
+9% +$49K ﹤0.01% 1894
2023
Q2 		$569K Sell
58,776
-283
-0.5% -$2.94K ﹤0.01% 1883
2023
Q1 		$647K Sell
59,059
-79
-0.1% -$696 ﹤0.01% 1803
2022
Q4 		$255K Buy
59,138
+55
+0.1% +$319 ﹤0.01% 2222
2022
Q3 		$445K Buy
59,083
+17,096
+41% +$148K ﹤0.01% 1938
2022
Q2 		$422K Buy
+41,987
New +$469K ﹤0.01% 1837

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NFG
Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's AUPH Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Aurinia Pharmaceuticals (AUPH) stake by 17% in Q2 2026, selling an estimated $18.9K and leaving 5,752 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Mirae Asset Global Investments first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $647K in Q1 2023. 109 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Mirae Asset Global Investments held 5,752 shares of Aurinia Pharmaceuticals worth $97.6K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,184 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $18.9K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1240 holding.
  • Mirae Asset Global Investments first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Aurinia Pharmaceuticals position peaked at $647K in Q1 2023.
  • 109 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.